Question 1

What is OTLK stock?

Accepted Answer

OTLK is the ticker symbol for Outlook Therapeutics, Inc., a publicly traded Healthcare sector company listed on Nasdaq. 13F Pro tracks OTLK with AI-powered analysis, an AI quality score, SEC EDGAR financials, insider transactions, and institutional 13F holdings — all sourced directly from public SEC filings.

Question 2

Is OTLK a good stock to buy?

Accepted Answer

13F Pro's AI ranking engine scores OTLK at 23.2/100, ranked #2,690 of 2,925 stocks on a composite quality score built from its SEC filings, covering profitability, growth, balance sheet strength, and free cash flow. The full AI verdict and bull/bear case for OTLK is available at https://13fpro.ai/company/OTLK. Not investment advice — review the underlying SEC filings before making any trade.

Question 3

Where does 13F Pro source OTLK data?

Accepted Answer

All Outlook Therapeutics, Inc. fundamentals and ownership data come directly from SEC EDGAR. Outlook Therapeutics, Inc. files with the SEC under CIK 1649989. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

Period	Form	Revenue	Net income	Op. marginOperating margin
FY 2025	10-K	$1.4M	$-62.4M	—
FY 2019	10-K	$8.1M	$-34.5M	—
FY 2018	10-K	$3.1M	$-30.1M	—
FY 2017	10-K	$3.8M	$-38.8M	—
FY 2016	10-K	$3.0M	$-53.3M	—
FY 2015	10-K	$5.2M	$-47.4M	—

Outlook Therapeutics, Inc. OTLK

Top Institutional Holders

Key Metrics

Financial Trends

Revenue & Net Income

Earnings Per Share

OTLK key financials by period

OTLK insiders

About Outlook Therapeutics, Inc. (OTLK): stock profile, AI score and financials